Diagnostics
Gen-Probe 2Q net income rises 42 percent on sales
July 29, 2010 4:45 pm | by The Associated Press | News | CommentsDiagnostic test maker Gen-Probe Inc. said Thursday its second-quarter net income jumped 42 percent on higher revenue from blood screening and women's health products.The company earned $28.1 million, or 57 cents per share, up from $19.8 million, or 38 cents per share, during the same period a...
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
July 29, 2010 4:33 am | by Becton, Dickinson and Company | News | Comments(July 28, 2010) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the promotion of Vincent A. Forlenza, President, who assumes the title of Chief Operating Officer in addition to his current title. Mr. Forlenza
Glucose Monitors Get Under the Skin
July 28, 2010 8:34 pm | by Massachusetts Institute of Technology | News | CommentsImplantable devices work in diabetic pigs for over a year--human tests could be next.
Siemens Showcases Broad Array of Innovative Diagnostic Solutions at 2010 AACC and ASCLS Annual Meetings and Clinical Lab Expo
July 28, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsANAHEIM, Calif. , July 28 /- Siemens Healthcare Diagnostics is showcasing a broad array of new products, services and solutions for clinicians at the American Association for Clinical Chemistry's 2010 Clinical Lab Expo in Anaheim, California from July 27 through July 29, 2010 (Booth...
Nanoblasts Move Molecules, Proteins and DNA into Living Cells
July 28, 2010 7:32 am | by Georgia Tech Institute of Technology | News | CommentsUsing chemical "nanoblasts" that punch tiny holes in the protective membranes of cells, researchers have demonstrated a new technique for getting therapeutic small molecules, proteins and DNA directly into living cells.
Speeding Up Diagnosis of Infectious Disease
July 27, 2010 8:35 pm | by Massachusetts Institute of Technology | News | CommentsA startup is developing sequencing-based tests that could detect infections within 24 hours.
Reform of primary care could reduce diagnostic errors
July 27, 2010 12:33 pm | by Baylor College of Medicine | News | CommentsErrors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant,...
Axela acquires Xceed Molecular
July 27, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | News | CommentsXceed Molecular, based in Toronto and Wellesley, has been acquired by Anaheim, Calif., based Axela Inc. which plans to provide clinical researchers with a suite of products for enhanced analysis of proteins, pathogens, DNA and RNA.
BD Board of Directors Elects Christopher Jones
July 27, 2010 8:34 am | by Becton, Dickinson and Company | News | Comments(July 26, 2010) -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it has elected Christopher Jones to its Board of Directors, effective today. Mr. Jones, 55, is the former Chief Executive Of
Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
July 27, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsSHENZHEN, China , July 27 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it will attend the 2010 American Association for Clinical Chemistry (AACC) conference in...
Moffitt Cancer Center and CvergenX, Inc. Sign Licensing Agreement
July 27, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsTAMPA, Fla. , July 27 /- Moffitt Cancer Center and CvergenX, Inc. , announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™....
Abviva Announces Notice of Canadian Patent for Technology Used in Breast Cancer Diagnostics and Therapeutics
July 26, 2010 8:32 am | by Bio-Medicine.Org | News | CommentsSANTA BARBARA, Calif. , July 26 /- Abviva, Inc. (Pink Sheets: ABVV), a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent...
The Marilyn B. Gula Mountains of Hope Foundation donates additional research funds to TGen
July 26, 2010 12:32 am | by EurekAlert | News | Comments(The Translational Genomics Research Institute) The Marilyn B. Gula Mountains of Hope Foundation continues its fight against advanced breast cancer with a $50,000 donation to the Phoenix-based Translational Genomics Research Institute (TGen), for a total contribution over two years of $300,000.
Vermillion Announces Relocation of Corporate Offices to Austin, Texas
July 23, 2010 4:35 pm | by Bio-Medicine.Org | News | CommentsFREMONT, Calif. , July 23 /- Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, today announced that it is relocating its corporate headquarters from Fremont, California to Austin, Texas . Vermillion has executed a two-year lease for a new principal place of business...
IDEXX claws out modest growth in Q2
July 23, 2010 5:33 am | by Mass High Tech: The Journal of New England Technology | News | CommentsMaine's IDEXX Laboratories Inc. posted moderate gains in revenue and profit for the second quarter of the year, almost entirely driven by sales from its pet-care division, the Companion Animal Group. IDEXX saw revenue grow to $281.5 million from $265.7 million for Q2 of 2009.
EndoChoice® Triples Facility Space to Address Growing Customer Base
July 21, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsALPHARETTA, Ga. , July 21 /- EndoChoice, Inc. today announced that it has moved its corporate headquarters to a new location in Alpharetta, Georgia . The new 30,000 square foot corporate headquarters is three times larger than its previous facility, and features a state-of-the-art...
Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
July 21, 2010 6:32 am | by Bio-Medicine.Org | News | CommentsWALTHAM, Mass. , July 21 /- Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) (NYSE: ALR ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release...
DiagnosisONE takes $5M from Edison Venture
July 20, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | News | CommentsHealth-care software provider DiagnosisONE Inc. of Nashua, N.H., has raised $5 million from Edison Venture Fund to expand its sales and marketing efforts, as well as further product development, officials said.
Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership
July 20, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsNORTH ATTLEBORO, Mass. , July 20 /- Medical Device Consultants, Inc. (MDCI), a full-service regulatory consulting and contract research organization (CRO) serving the medical device and diagnostics industry, today announced a strategic partnership with Clinical Development & Support...
Sysmex America Begins Distribution of CellaVision® DM1200
July 20, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsMUNDELEIN, Ill. , July 20 /- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced the addition of the CellaVision® DM1200 cell image analysis analyzer to the Sysmex hematology product offering. The DM1200 enables...
Foundation Radiology Group Forms Strategic Partnership with Transcription Experts, Acusis
July 20, 2010 7:31 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH , July 20 /- Pittsburgh -based Foundation Radiology Group (FRG), a premier provider of high-quality, diagnostic imaging professional services, is proud to announce its strategic partnership with Acusis, a national provider of outsourced medical transcription services for...
Image-processing algorithm reduces CT radiation dose by as much as 95 percent
July 20, 2010 4:32 am | by EurekAlert | News | Comments(American Institute of Physics) In the wake of recent radiation overdoses, researchers at the Mayo Clinic, excited by CT perfusion's promise for diagnosing stroke, cancer, and possibly heart disease, have developed a way to reduce the amount of radiation involved in the procedure...
New biotech company grows from MCG diabetes and genomic research
July 19, 2010 6:34 am | by EurekAlert | News | Comments(Medical College of Georgia) A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer. Dr. Jin-Xiong She, director of the MCG Center for Biotechnology and...
MDMA (Ecstasy)-assisted psychotherapy relieves treatment-resistant PTSD
July 19, 2010 4:31 am | by EurekAlert | News | Comments(SAGE Publications UK) MDMA (also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE,...
China Sky One Medical's Chief Financial Officer's Health Issues to Restrict His Availability to Investors
July 16, 2010 5:34 pm | by Bio-Medicine.Org | News | CommentsHARBIN, China , July 16 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that...
